Drug companies look to AI to end ‘hit and miss’ research

Technology that speeded the development of Covid vaccines has potential to transform the pharmaceutical industry

The hunt for new medicines has often been more like a game of roulette than high-end science. But now the pharmaceutical sector is on the cusp of a transformation, as it delves into cutting-edge technology to come up with new treatments for diseases such as cancer, rheumatoid arthritis and Alzheimer’s.

Artificial intelligence (AI) is set to improve the industry’s success rates and speed up drug discovery, potentially saving it billions of dollars, a recent survey by the analytics firm GlobalData has found. AI topped a list of technologies seen as having the greatest impact on the sector this year. Almost 100 partnerships have been struck between AI specialists and large pharma companies for drug discovery since 2015.

Continue reading…

Kaiser Permanente joins forces with Accenture, Microsoft to improve cloud capabilities

hand touching visual screen

The California-based healthcare organization will work with Accenture and Microsoft to grow and strengthen its cloud capabilities. The enhancements are expected to help Kaiser provide its care teams with data insights to personalize patient care.